RSS Feeds
β-Blocker-Induced Quadriparesis
- Hassane Izzedine, MD;
- Vincent Launay-Vacher, PharmD;
- Jean Sebastien Hulot, MD;
- Damien Sternberg, MD; and
- Gilbert Deray, MD
- From Hôpital Pitié-Salpêtrière, 75013 Paris, France.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Background and Objective: Acute quadriplegic myopathy (AQM) may manifest when corticosteroids and neuromuscular blocking agents are coadministered. We report what we believe to be the first case of β-blocker–induced AQM.
Case Report: A 56-year-old male anephric patient who was undergoing hemodialysis was admitted because of weakness in his legs and …
